Bausch + Lomb (BLCO) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
350.0mn → 353.8mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.
+19.9% YoY in FY25 · 6.8% of revenue.
$9.0M returned vs $−66.0M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.
-7¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Over this window: gross 61.0% → 59.8%. Net margin -7.1% is below the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 5,418.0 | 5,101.0 | 4,791.0 | 4,146.0 | 3,768.0 | 3,765.0 | ▲6.5% | +7.9% |
Cost of revenue | 2,029.0 | 2,050.0 | 1,872.0 | 1,642.0 | 1,519.0 | 1,467.0 | ▲9.5% | +8.7% |
Gross profit | 3,389.0 | 3,051.0 | 2,919.0 | 2,504.0 | 2,249.0 | 2,298.0 | ▲4.5% | +7.3% |
Research & development | 400.0 | 371.0 | 343.0 | 324.0 | 307.0 | 271.0 | ▲8.2% | +8.2% |
Selling, general & admin | 2,252.0 | 2,234.0 | 2,082.0 | 1,736.0 | 1,478.0 | 1,389.0 | ▲7.3% | +12.6% |
Total operating expenses | 3,006.0 | 2,938.0 | 2,757.0 | 2,374.0 | 2,042.0 | 1,969.0 | ▲6.6% | +10.5% |
Operating incomefeeds ROC rank | 383.0 | 113.0 | 162.0 | 130.0 | 207.0 | 329.0 | ▼30.2% | −23.4% |
Other income, net | −387.0 | −430.0 | −396.0 | −296.0 | −134.0 | −11.0 | — | — |
Pretax income | −4.0 | −317.0 | −234.0 | −166.0 | 73.0 | 318.0 | ▼35.5% | — |
Income tax | 99.0 | 35.0 | 71.0 | 82.0 | 58.0 | 125.0 | ▼50.7% | −27.3% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −111.0 | −360.0 | −317.0 | −260.0 | 6.0 | 193.0 | ▼13.6% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.31 | −1.02 | −0.90 | −0.74 | 0.02 | 0.52 | ▼13.3% | — |
Diluted shares (mn) | 361.50 | 353.80 | 351.80 | 350.50 | 350.20 | 350.00 | ▲0.6% | +0.3% |
| Margins | ||||||||
Gross margin44th pct in Healthcare | 62.6% | 59.8% | 60.9% | 60.4% | 59.7% | 61.0% | ▼1.1pp | −1.2pp |
Operating margin | 7.1% | 2.2% | 3.4% | 3.1% | 5.5% | 8.7% | ▼1.2pp | −6.5pp |
Net margin36th pct in Healthcare | −2.0% | −7.1% | −6.6% | −6.3% | 0.2% | 5.1% | ▼0.4pp | −12.2pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Bausch + Lomb's revenue last fiscal year?
Bausch + Lomb reported revenue of $5,101.0M in fiscal 2025, up 6.5% from fiscal 2024.
What was Bausch + Lomb's net income?
Bausch + Lomb reported net income of −$360.0M in fiscal 2025, a net margin of −7.1%.

